Stay updated on Tislelizumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab Combo in NSCLC Clinical Trial page.

Latest updates to the Tislelizumab Combo in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe clinical trial record now lists the study as completed, replacing its prior “Active, not recruiting” status. The record also reflects a new update and changes to study status, recruitment status, study design, and arms and interventions.SummaryDifference0.6%

- Check20 days agoChange DetectedA banner announces NIH website updates and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.5%

- Check27 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check34 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check55 days agoChange DetectedA new system revision entry 'Revision: v3.7.0' was added to the history, replacing the previous 'Revision: v3.6.6'. This appears to be an administrative update to the page/interface rather than a modification to study data or content.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision entry (v3.6.6) was added to the study record history. The previous revision (v3.6.5) was removed from the history list.SummaryDifference0.1%

Stay in the know with updates to Tislelizumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab Combo in NSCLC Clinical Trial page.